Dimensional Fund Advisors LP lifted its holdings in shares of Stericycle Inc (NASDAQ:SRCL) by 1.8% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 716,864 shares of the business services provider’s stock after buying an additional 12,940 shares during the quarter. Dimensional Fund Advisors LP’s holdings in Stericycle were worth $41,960,000 at the end of the most recent quarter.
Several other hedge funds have also made changes to their positions in SRCL. Zions Bancorporation purchased a new stake in shares of Stericycle during the 1st quarter valued at approximately $122,000. Federated Investors Inc. PA lifted its stake in shares of Stericycle by 129.5% during the 1st quarter. Federated Investors Inc. PA now owns 2,088 shares of the business services provider’s stock valued at $122,000 after buying an additional 1,178 shares in the last quarter. Fuller & Thaler Asset Management Inc. lifted its stake in shares of Stericycle by 500.0% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 3,000 shares of the business services provider’s stock valued at $204,000 after buying an additional 2,500 shares in the last quarter. Investors Research Corp purchased a new stake in shares of Stericycle during the 4th quarter valued at approximately $212,000. Finally, Allianz Asset Management GmbH purchased a new stake in shares of Stericycle during the 4th quarter valued at approximately $229,000. Institutional investors own 97.56% of the company’s stock.
Stericycle opened at $65.29 on Friday, according to Marketbeat. Stericycle Inc has a 1 year low of $56.64 and a 1 year high of $83.25. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.81 and a current ratio of 0.81. The company has a market capitalization of $5.53 billion, a price-to-earnings ratio of 15.04, a PEG ratio of 1.45 and a beta of 0.41.
Stericycle (NASDAQ:SRCL) last posted its earnings results on Thursday, May 3rd. The business services provider reported $1.21 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.05 by $0.16. Stericycle had a net margin of 0.19% and a return on equity of 14.14%. The business had revenue of $895.00 million for the quarter, compared to analysts’ expectations of $880.48 million. During the same period in the prior year, the company posted $1.09 EPS. The business’s revenue for the quarter was up .3% compared to the same quarter last year. research analysts forecast that Stericycle Inc will post 4.63 EPS for the current fiscal year.
A number of analysts recently commented on the stock. ValuEngine cut shares of Stericycle from a “sell” rating to a “strong sell” rating in a research note on Wednesday, May 2nd. BMO Capital Markets upped their price target on shares of Stericycle from $64.00 to $67.00 and gave the company a “market perform” rating in a research note on Friday, May 4th. Barrington Research reiterated a “buy” rating on shares of Stericycle in a research note on Friday, June 1st. Finally, BidaskClub upgraded shares of Stericycle from a “hold” rating to a “buy” rating in a research note on Wednesday, March 21st. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating and four have given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $78.63.
In other news, CEO Charles A. Alutto sold 14,000 shares of the firm’s stock in a transaction on Tuesday, May 22nd. The shares were sold at an average price of $64.02, for a total transaction of $896,280.00. Following the sale, the chief executive officer now owns 18,026 shares in the company, valued at approximately $1,154,024.52. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director John Patience sold 6,624 shares of the firm’s stock in a transaction on Wednesday, May 23rd. The shares were sold at an average price of $63.15, for a total transaction of $418,305.60. Following the sale, the director now owns 156,734 shares in the company, valued at approximately $9,897,752.10. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 46,834 shares of company stock worth $2,966,543. Corporate insiders own 3.50% of the company’s stock.
Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It collects and processes regulated and specialized waste for disposal services; and collects personal and confidential information for secure destruction, as well as offers training, consulting, recall/return, communication, and compliance services.
Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle Inc (NASDAQ:SRCL).
Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.